/epidemic-and-pandemic-preparedness-and-prevention-(epp)/global-influenza-programme-(gip)/screenshot-of-vcm-report.tmb-144v.png?sfvrsn=8d570ca2_1)
25 September 2026
Recommended composition of influenza virus vaccines for use in the 2027 southern hemisphere influenza...
For vaccines for use in the 2027 southern hemisphere influenza season, WHO recommends the following: Egg-based vaccines • an A/Missouri/11/2025 (H1N1)pdm09-like...
/epidemic-and-pandemic-preparedness-and-prevention-(epp)/global-influenza-programme-(gip)/cvv-seasonal-cover-image.tmb-144v.png?sfvrsn=fc8faf9d_1)
25 September 2026
Seasonal candidate vaccine viruses and potency testing reagents for development and production of vaccines
The candidate vaccine viruses listed below, and associated information, are available for the development and production of influenza vaccines for use...
/epidemic-and-pandemic-preparedness-and-prevention-(epp)/global-influenza-programme-(gip)/global-respiratory-virus-activity-weekly-update.tmb-144v.png?sfvrsn=8b4f467c_2)
23 September 2026
Global Respiratory Virus Activity: Weekly Update N° 596
In week 37 2026, globally, influenza positivity was at 10% and SARS-CoV-2 positivity remained stable and low. Influenza positivity was under 10% in the...
16 September 2026
Global Respiratory Virus Activity: Weekly Update N° 595
In week 36 2026, globally, influenza positivity was around 10% and SARS-CoV-2 positivity remained stable and low. Influenza positivity was at 10% in the...